Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#413 most reported symptom for this vaccine
Respiratory rate increased has been reported 113 times in association with Influenza, Seasonal (Fluvirin) vaccination in VAERS. This represents 0.1% of all 119,695 reports for this vaccine.
Among these reports, 8 mentioned death (7.08%) and 19 involved hospitalization (16.8%).
Respiratory rate increased is the #413 most frequently reported symptom for Influenza, Seasonal (Fluvirin) out of 3021 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 113 reports of Respiratory rate increased after Influenza, Seasonal (Fluvirin) vaccination may seem alarming, but context is critical. With 119,695 total reports for this vaccine (representing many millions of doses), Respiratory rate increased appears in only 0.1% of reports.
The 7.08% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.